Imunon (IMNN) Current Leases (2019 - 2026)
Imunon's (IMNN) quarterly Current Leases came in at $418903.0 in Q1 2026, up 6.08% YoY from $394878.0 in Q1 2025, and up 3.09% on a QoQ basis from $406354.0 in Q4 2025.
Imunon (IMNN) Current Leases (2019 - 2026) Analysis & Trends
Imunon (IMNN) has 8 years of Current Leases data on file, last reported at $418903.0 in Q1 2026.
- Quarterly Current Leases rose 6.08% year-over-year to $418903.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $418903.0 (up 6.08% YoY) and the FY2025 annual result came in at $406354.0, down 10.17% from the prior year.
- Current Leases rose to $418903.0 in Q1 2026, from $406354.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $516545.0 in Q1 2022 to a low of $230749.0 in Q4 2022.
- A 5-year average of $414381.2 and a median of $412628.5 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases sank 57.96% — and 2023, when it surged 110.37%.
- Tracing IMNN's Current Leases over 5 years: stood at $230749.0 in 2022, then soared by 110.37% to $485421.0 in 2023, then fell by 6.81% to $452358.0 in 2024, then slipped by 10.17% to $406354.0 in 2025, then climbed by 3.09% to $418903.0 in 2026.
- The last three Current Leases figures came in at $418903.0 (Q1 2026), $406354.0 (Q4 2025), and $394135.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | - |
| 10 | Imunon | 8.58 Mn | 8.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418,903.00 |
| Dec 31, 2025 | 406,354.00 |
| Sep 30, 2025 | 394,135.00 |
| Jun 30, 2025 | 382,217.00 |
| Mar 31, 2025 | 394,878.00 |
| Dec 31, 2024 | 452,358.00 |
| Jun 30, 2024 | 516,223.00 |
| Mar 31, 2024 | 500,625.00 |
| Dec 31, 2023 | 485,421.00 |
| Sep 30, 2023 | 470,613.00 |
| Jun 30, 2023 | 278,409.00 |
| Mar 31, 2023 | 349,602.00 |
| Dec 31, 2022 | 230,749.00 |
| Sep 30, 2022 | 373,525.00 |
| Jun 30, 2022 | 459,542.00 |
| Mar 31, 2022 | 516,545.00 |
| Dec 31, 2021 | 548,870.00 |
| Sep 30, 2021 | 534,256.00 |
| Jun 30, 2021 | 458,168.00 |
| Mar 31, 2021 | 445,560.00 |